A
Anne Lingford-Hughes
Researcher at Imperial College London
Publications - 220
Citations - 9521
Anne Lingford-Hughes is an academic researcher from Imperial College London. The author has contributed to research in topics: Addiction & Alcohol dependence. The author has an hindex of 46, co-authored 201 publications receiving 8304 citations. Previous affiliations of Anne Lingford-Hughes include National Institutes of Health & University of Sydney.
Papers
More filters
Journal ArticleDOI
Cannabis use and risk of psychotic or affective mental health outcomes: a systematic review
Theresa Hm Moore,Stanley Zammit,Stanley Zammit,Anne Lingford-Hughes,Thomas R. E. Barnes,Peter B. Jones,Margaret Burke,Glyn Lewis +7 more
TL;DR: There is now sufficient evidence to warn young people that using cannabis could increase their risk of developing a psychotic illness later in life, although evidence for affective outcomes is less strong.
Journal ArticleDOI
The dopamine theory of addiction: 40 years of highs and lows
TL;DR: There is good evidence that striatal dopamine receptor availability and dopamine release are diminished in individuals with stimulant or alcohol dependence but not in Individuals with opiate, nicotine or cannabis dependence, which has implications for understanding reward and treatment responses in various addictions.
Journal ArticleDOI
Effects of cannabis use on outcomes of psychotic disorders: systematic review.
Stanley Zammit,Theresa Hm Moore,Anne Lingford-Hughes,Thomas R. E. Barnes,Peter B. Jones,Margaret Burke,Glyn Lewis +6 more
TL;DR: Confidence that most associations reported were specifically due to cannabis is low, and it remains important to establish whether cannabis is harmful, what outcomes are particularly susceptible, and how such effects are mediated.
Journal ArticleDOI
BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP
TL;DR: The guidelines primarily cover the pharmacological management of withdrawal, short- and long-term substitution, maintenance of abstinence and prevention of complications, where appropriate, for substance abuse or harmful use or addiction as well management in pregnancy, comorbidity with psychiatric disorders and in younger and older people.
Journal ArticleDOI
BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatment
Stephen Cooper,Gavin P. Reynolds,Thomas R. E. Barnes,Elizabeth England,Peter M. Haddad,Adrian H. Heald,Richard I. G. Holt,Anne Lingford-Hughes,David Osborn,Olga O McGowan,Maxine X. Patel,Carol Paton,P. Reid,David Shiers,Jo Smith +14 more
TL;DR: These guidelines review issues surrounding monitoring of physical health risk factors and make recommendations about an appropriate approach to interventions for people experiencing weight gain when taking antipsychotic medications.